Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-30 to 2023-05-31
Current total value of award: $7740.53
Description: 4561076408!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML